PHARMATEK · Gastroentérologie

Calculateur du MELD 3.0 actuel de l’OPTN pour adultes à l’inscription

Calculer la branche adulte en attente de révision de la politique écrite américaine 9.1.D de l’OPTN, avec des ajustements de laboratoire transparents et un entier final de 6 à 40.

Révision clinique en cours

La révision clinique doit être complétée.

Cet outil fait partie de la bibliothèque PharmaTek. Son calcul reste indisponible au public jusqu’à la validation de sa formule, de ses limites et de ses sources.

Explorer les outils accessibles

Sources, population et validation

État: clinical-review-pending
Version de la méthode: Current US OPTN Policy 9.1.D adult-at-registration MELD arithmetic, policy snapshot 2026-06-24 checked 2026-08-12: 1.33 if sex for purposes of adult MELD calculation is female + 4.56×ln(total bilirubin mg/dL) + 0.82×(137−sodium mEq/L) − 0.24×(137−sodium)×ln(bilirubin) + 9.09×ln(INR) + 11.14×ln(creatinine mg/dL) + 1.85×(3.5−albumin g/dL) − 1.83×(3.5−albumin)×ln(creatinine) + 6; bilirubin, INR, and creatinine below 1 are set to 1; creatinine above 3 or qualifying dialysis/CVVHD is set to 3; sodium is limited to 125–137 and albumin to 1.5–3.5; natural logs, no intermediate rounding, final arithmetic half-up whole number limited to written-policy range 6–40
Population: US liver-transplant candidates who were at least 18 years old at this waitlist registration and for whom the transplant program, in consultation with the candidate and clinical team, independently established the policy field sex for purposes of adult MELD calculation. Exact final total serum bilirubin, serum sodium, INR, serum creatinine, serum albumin, official units, applicable laboratory dates and context, and the two policy dialysis/CVVHD criteria relative to the creatinine test must be independently verified. This arithmetic does not establish whether laboratory certification, recertification, or the same-two-day voluntary-change rule is satisfied.
Limites et exclusions: Candidates who were younger than 18 at waitlist registration, including candidates now aged 18 or older; the separate adolescent branch with constant 7.33 and no adult sex term; PELD; or any inferred registration-age branch. · Inferring the sex-for-adult-MELD category from birth sex, gender identity, name, anatomy, laboratory values, or therapy; an unknown category or dialysis/CVVHD history; missing albumin; imputed, carried-forward, mismatched, uncertified, or unverified values or units. · Calling this output an authoritative allocation MELD, allocation priority, candidacy or eligibility decision, Status 1A/1B, exception score, liver-intestine point total, certified or current OPTN record, match-run result, mortality probability, risk category, diagnosis, prognosis, or treatment recommendation. · Delaying, withholding, or altering indicated albumin, dialysis, CVVHD, anticoagulation, or other care to influence score arithmetic; any treatment, listing, allocation, management, or disposition decision. · The uncapped 2021 research MELD 3.0 score above 40. This implementation follows the current written OPTN adult policy's 6–40 limit and is not interchangeable with the uncapped research output.

Origine de l’outil PharmaTek

Outil importé de la bibliothèque PharmaTek de MDose. Aucune date de révision clinique indépendante n’est documentée dans cette version.

Bibliothèque source: PharmaTek · MDose
Version importée: 4b66536936ed
État de publication: Révision clinique en cours

POURSUIVRE AVEC MDOSE

Un outil. Un premier lien.

Recevez des nouvelles des outils ou discutez d’une collaboration. L’utilisation de PharmaTek reste accessible sans laisser vos coordonnées.

Médecins et partenaires